From the Department of Anesthesia and Critical Care Medicine (D.S.P., A.A.T.), Department of Pediatrics, Division of Neurology (F.W.F., M.J., D.S.P., N.S.A.), and Department of Neurodiagnostics (L.V., M.D., N.S.A.), Children's Hospital of Philadelphia; and Departments of Neurology (N.S.A., F.W.F.), Pediatrics (N.S.A., F.W.F.), Anesthesia and Critical Care (A.A.T., N.S.A.), and Biostatistics, Epidemiology and Informatics (J.F., R.X., N.S.A.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
Neurology. 2020 Sep 15;95(11):e1599-e1608. doi: 10.1212/WNL.0000000000010421. Epub 2020 Jul 20.
To determine the optimal duration of continuous EEG monitoring (CEEG) for electrographic seizure (ES) identification in critically ill children.
We performed a prospective observational cohort study of 719 consecutive critically ill children with encephalopathy. We evaluated baseline clinical risk factors (age and prior clinically evident seizures) and emergent CEEG risk factors (epileptiform discharges and ictal-interictal continuum patterns) using a multistate survival model. For each subgroup, we determined the CEEG duration for which the risk of ES was <5% and <2%.
ES occurred in 184 children (26%). Patients achieved <5% risk of ES after (1) 6 hours if ≥1 year without prior seizures or EEG risk factors; (2) 1 day if <1 year without prior seizures or EEG risks; (3) 1 day if ≥1 year with either prior seizures or EEG risks; (4) 2 days if ≥1 year with prior seizures and EEG risks; (5) 2 days if <1 year without prior seizures but with EEG risks; and (6) 2.5 days if <1 year with prior seizures regardless of the presence of EEG risks. Patients achieved <2% risk of ES at the same durations except patients without prior seizures or EEG risk factors would require longer CEEG (1.5 days if <1 year of age, 1 day if ≥1 year of age).
A model derived from 2 baseline clinical risk factors and emergent EEG risk factors would allow clinicians to implement personalized strategies that optimally target limited CEEG resources. This would enable more widespread use of CEEG-guided management as a potential neuroprotective strategy.
NCT03419260.
确定连续脑电图监测(CEEG)识别危重病儿童电临床发作(ES)的最佳持续时间。
我们对 719 例连续患有脑病的危重病儿童进行了前瞻性观察队列研究。我们使用多状态生存模型评估了基线临床危险因素(年龄和既往临床明显发作)和紧急 CEEG 危险因素(癫痫样放电和发作-发作间连续模式)。对于每个亚组,我们确定了 ES 风险<5%和<2%的 CEEG 持续时间。
184 名儿童(26%)发生 ES。如果满足以下条件,患者在以下时间后达到 ES 风险<5%:(1)≥1 岁且无既往发作或 EEG 危险因素,则为 6 小时;(2)<1 岁且无既往发作或 EEG 危险因素,则为 1 天;(3)≥1 岁且有既往发作或 EEG 危险因素,则为 1 天;(4)≥1 岁且有既往发作和 EEG 危险因素,则为 2 天;(5)<1 岁且无既往发作但有 EEG 危险因素,则为 2 天;(6)<1 岁且有既往发作,无论是否有 EEG 危险因素,则为 2.5 天。如果没有既往发作或 EEG 危险因素,患者达到 ES 风险<2%的时间也相同,但需要更长的 CEEG(<1 岁时为 1.5 天,≥1 岁时为 1 天)。
从 2 个基线临床危险因素和紧急 EEG 危险因素得出的模型可以使临床医生实施最佳的个性化策略,从而优化有限的 CEEG 资源。这将使更多的患者能够使用 CEEG 指导的管理作为潜在的神经保护策略。
临床试验.gov 标识符:NCT03419260。